Literature DB >> 18287573

Neurologic manifestations of pediatric chikungunya infection.

Stéphanie Robin1, Duksha Ramful, Florence Le Seach', Marie-Christine Jaffar-Bandjee, Gérald Rigou, Jean-Luc Alessandri.   

Abstract

Chikungunya virus, a mosquito-borne arbovirus, was responsible for a massive epidemic in La Réunion Island during 2005 to 2006. The disease is usually benign, but neurologic involvement, with sometimes fatal outcome, has been described. We report a retrospective hospital-based pediatric series of 30 children (23 boys and 7 girls) who presented neurologic manifestations of chikungunya such as encephalitis (n = 12), febrile seizures (n = 10), meningeal syndrome (n = 4), and acute encephalopathy (n = 4). Cerebrospinal fluid biological and cytological analyses (n = 23) were unremarkable except for 1 case of acute disseminated encephalomyelitis. The presence of viral genome in cerebrospinal fluid was inconstantly positive. Brain magnetic resonance imaging (MRI) scans (n = 14) were abnormal in 5 cases. Electroencephalography was nonspecific. Two patients died. At discharge and 6 months later, 5 children had neurologic sequelae. Patients with initial severe neurologic presentation and having pathological brain MRI had more sequelae or fatal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287573     DOI: 10.1177/0883073808314151

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  56 in total

1.  Case reports of neuro-Chikungunya in southern Thailand.

Authors:  Sarunyou Chusri; Pisud Siripaitoon; Siriporn Hirunpat; Khachornsakdi Silpapojakul
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

Review 2.  Emerging viral infections of the central nervous system: part 2.

Authors:  Kenneth L Tyler
Journal:  Arch Neurol       Date:  2009-09

3.  Perinatal Outcomes in Vertically Infected Neonates During a Chikungunya Outbreak on the Island of Curaçao.

Authors:  Bert J D van Enter; Minke H W Huibers; Linda van Rooij; Radjinkoemar Steingrover; Michael Boele van Hensbroek; Ralph R Voigt; Jeroen Hol
Journal:  Am J Trop Med Hyg       Date:  2018-12       Impact factor: 2.345

Review 4.  Chikungunya: a potentially emerging epidemic?

Authors:  Michelle M Thiboutot; Senthil Kannan; Omkar U Kawalekar; Devon J Shedlock; Amir S Khan; Gopalsamy Sarangan; Padma Srikanth; David B Weiner; Karuppiah Muthumani
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

5.  Chimeric alphavirus vaccine candidates for chikungunya.

Authors:  Eryu Wang; Eugenia Volkova; A Paige Adams; Naomi Forrester; Shu-Yuan Xiao; Ilya Frolov; Scott C Weaver
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

6.  Phylogenetic analyses of chikungunya virus among travelers in Rio de Janeiro, Brazil, 2014-2015.

Authors:  Liliane Costa Conteville; Louise Zanella; Michel Abanto Marín; Ana Maria Bispo de Filippis; Rita Maria Ribeiro Nogueira; Ana Carolina Paulo Vicente; Marcos César Lima de Mendonça
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03-29       Impact factor: 2.743

Review 7.  Treatment of perinatal viral infections to improve neurologic outcomes.

Authors:  William J Muller
Journal:  Pediatr Res       Date:  2016-09-27       Impact factor: 3.756

Review 8.  Present and future arboviral threats.

Authors:  Scott C Weaver; William K Reisen
Journal:  Antiviral Res       Date:  2009-10-24       Impact factor: 5.970

9.  A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.

Authors:  Shirley Lam; Min Nyo; Patchara Phuektes; Chow Wenn Yew; Yee Joo Tan; Justin Jang Hann Chu
Journal:  MAbs       Date:  2015-08-25       Impact factor: 5.857

10.  Chikungunya virus and central nervous system infections in children, India.

Authors:  Penny Lewthwaite; Ravi Vasanthapuram; Jane C Osborne; Ashia Begum; Jenna L M Plank; M Veera Shankar; Roger Hewson; Anita Desai; Nick J Beeching; Ravi Ravikumar; Tom Solomon
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.